Omega Diagnostics Group has conditionally agreed to sell its diagnostic test-kit manufacturing business and facility in Scotland to Accubio for one million pounds ($1.4 million) in cash.rnThe Sale is conditional on, amongst other things, the execution of a comprehensive transitional services agreement in line with the principles which have been agreed, the consent of the landlord to assign the Alva lease and the Secretary of State for the Department of Business, Energy and Industrial Strategy not issuing a Public Interest Intervention Notice requiring a review of the Sale, in each case prior to 7 March 2022.<br><br>rnThe manufacturing business is being sold as a going concern with approximately 109 full-time employees based in Alva transferring across with the business, with no resultant redundancies.<br><br>rnThe Agreement also covers the sale of certain fixed assets, including plant and equipment (although not any Government-funded equipment on site), as well as the assignment of the lease for the Alva site.<br><br>rnAs part of the Alva exit plan, Omega is facilitating discussions with several manufacturing partners who may be willing to purchase the Government-funded equipment from the DHSC.<br><br>rnOmega does not intend to purchase the equipment
ttps://www.histerius.com/hs0222/omega_diagnostics.jpg" class="slikadesno" title="Omega Diagnostics" alt="Omega Diagnostics">Omega Diagnostics Group has conditionally agreed to sell its diagnostic test-kit manufacturing business and facility in Scotland to Accubio for one million pounds ($1.4 million) in cash.
The Sale is conditional on, amongst other things, the execution of a comprehensive transitional services agreement in line with the principles which have been agreed, the consent of the landlord to assign the Alva lease and the Secretary of State for the Department of Business, Energy and Industrial Strategy not issuing a Public Interest Intervention Notice requiring a review of the Sale, in each case prior to 7 March 2022.
The manufacturing business is being sold as a going concern with approximately 109 full-time employees based in Alva transferring across with the business, with no resultant redundancies.
The Agreement also covers the sale of certain fixed assets, including plant and equipment (although not any Government-funded equipment on site), as well as the assignment of the lease for the Alva site.
As part of the Alva exit plan, Omega is facilitating discussions with several manufacturing partners who may be willing to purchase the Government-funded equipment from the DHSC.
Omega does not intend to purchase the equipment for its own use and remains in discussion with the DHSC with regards to the £2.5m pre-production payment provided. ■